Swiss Market Ends On Firm Note

Swiss equities closed firmer, with the SMI rising 0.6% to 12,333.93 as markets remained supported by expectations for interest-rate cuts from several central banks, including the Federal Reserve. Roche Holding was the standout gainer, jumping about 5.8% after reporting positive early-stage clinical trial results for a new weight-loss pill under development. Other notable gainers included Swatch Group and Nestle, while weakness in VAT Group, Logitech, Givaudan, Partners Group, Richemont, Julius Baer, Sonova, UBS Group, Kuehne + Nagel, ABB, Lonza, SGS, Holcim and Swiss Re limited the broader move. Overall, the article signals a constructive tone for Swiss market sentiment, driven by macro easing hopes and a company-specific biotech catalyst for Roche.